IP25-20: Fully hybrid 18F-PSMA PET/MRI as a One-Stop Approach for the Diagnosis of Clinically-Significant Prostate Cancer: Preplanned Interim Results from a Phase II Prospective Trial

IP25-20: Fully hybrid 18F-PSMA PET/MRI as a One-Stop Approach for the Diagnosis of Clinically-Significant Prostate Cancer: Preplanned Interim Results from a Phase II Prospective Trial

Saturday, May 16, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
145AB
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!